| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3992190 | Journal of Thoracic Oncology | 2009 | 5 Pages |
Abstract
Although the initial PET SUVmax does not predict survival in patients with locally advanced esophageal adenocarcinoma who receive preoperative chemoradiotherapy, patients with a high initial SUVmax respond better to preoperative therapy. These results can be used to better select esophageal cancer patients for combined modality treatment.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Nabil P. MD, Laura MD, PhD, Prasad S. MD, Manjit S. MD, Timothy J. MD, David MD, PhD, Karyn MD, Valerie W. MD,